Chimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center
Alexander D. Heini(University of Bern), Thomas Pabst(University Hospital of Bern), Ulrike Bacher(Hattiesburg Clinic), Urban Novak(University of Bern), Sacha Zeerleder(University of Amsterdam), Behrouz Mansouri Taleghani(University of Bern), Marie-Noëlle Kronig(University Hospital of Bern), Gertrud Wiedemann(University of Bern), Michael Daskalakis(University of Bern)
Cited by 10
Related Papers
Prognostic relevance of FLT3-TKD mutations in AML: the combination matters—an analysis of 3082 patients
|Blood|2007|410
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome
|Blood|2010|189
Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center
|Leukemia|2014|172